Depends on how quickly they enroll and when the trial is finished. I'm guessing the 1/2 point in the trial will be mid 2014 and we should get a good update on how patients are doing at that time. Should also get a few updates before that on how the patients in Europe are doing with their c-pulse devices.
So a few years out until actual FDA approval? Really like the chances and potential. Took a small position after doing some DD but still need to continue researching it. thanks for your help
any other info you can share on the company?
also, why the drop to $2.50, was it because of dilution?